Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

Compare more Oncology professors.

h-index76
i10-index249
Publications650
Citations40,564

Grants

8 total · 0 active

NIH #UG1CA233270

Vanderbilt Network Lead Academic Participating Site for the NCTN

Amount
$500K–$600K
Period
2019-03-07 → 2025-02-28
PIs
1

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #U24CA220325

VU PREDICT

Amount
$600K–$700K
Period
2018-09-14 → 2023-08-31
PIs
2

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #UM1CA186689

ViKTriY-PC Consortium Phase II Supplement

Amount
$700K–$800K
Period
2014-07-10 → 2020-02-29
PIs
2

Awarded at YALE UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 0 active

NIH #UG1CA233270

Vanderbilt Network Lead Academic Participating Site for the NCTN

Amount
$500K–$600K
Period
2019-03-07 → 2025-02-28
PIs
1

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #U24CA220325

VU PREDICT

Amount
$600K–$700K
Period
2018-09-14 → 2023-08-31
PIs
2

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #UM1CA186689

ViKTriY-PC Consortium Phase II Supplement

Amount
$700K–$800K
Period
2014-07-10 → 2020-02-29
PIs
2

Awarded at YALE UNIVERSITY

NIH #U10CA180847

Vanderbilt Network Lead Academic Participating Site for the NCTN

Amount
$500K–$600K
Period
2014-04-17 → 2019-02-28
PIs
1

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #U10CA049957

Eastern Cooperative Oncology Group

Amount
$300K–$400K
Period
1989-05-01 → 2016-04-30
PIs
1

NIH #P50CA095103

Targeting K-Ras in CRC

Amount
$200K–$300K
Period
2002-09-24 → 2016-04-29
PIs
1

NIH #P50CA236733

Project 2: Targeting Glutamine Metabolism to Enhance EGFR Blockade in Wild-Type RAS CRC

Amount
$400K–$500K
Period
— → —
PIs
1

Awarded at VANDERBILT UNIVERSITY MEDICAL CENTER

NIH #P30CA068485

Clinical Trials Shared Resource

Amount
$400K–$500K
Period
— → —
PIs
1

Recent Public Signals

  1. New paper: Table S9 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer2026-06-17

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-21

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-7571-2385

Professor Insights

Career Trajectory